Publications 2005

Below our publications are listed using several headings. Scientific publications relate to original research, often published internationally, but also in the Dutch language. Professional publications are in Dutch and relate to reviews and expressions of opinions.

A few publications have no links. Reprints can be requested by our secretary.

Back to homepage

Scientific Publications National
al Hadithy AFY, de Boer NKH, Derijks LJJ, Escher JC, Mulder CJJ, Brouwers JRBJ. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Digestive and Liver Disease 2005;36:282-97
al Hadithy AFY, Naunton M, Brouwers JRBJ. Thiopurines for inflammatory bowel disease: role of pharmacogenetics. Journal of Pharmacy Practice and Research 2005;35(3):213-5
Atthobari J, Bos JM, Boersma C, Brouwers JRBJ, de Jong-van den Berg LTW, Postma MJ. Adherence of pharmacoeconomic studies to national guidelines in the Netherlands. Pharmacy World & Science2005;27:364-70
Boersma C, Klok RM, Bos JM, Naunton M, van den Berg PB, de Jong-van den Berg LTW, Postma MJ.Drug costs developments after patent expiry of enalapril, fluoxetine and ranitidine. Applied Health Economics and Helath Policy 2005;4(3):191-6
Bos JM, Postma MJ, Annemans L. Discounting health effects in pharmacoeconomic evaluations. Current controversies. Pharmacoeconomics 2005;23(7):639-49
Brouwer WBF, Niessen LW, Postma MJ, Rutten FFH.Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ2005;331(aug):446-8
Cornel MC, de Smit DJ, de Jong-van den Berg LTW.Folic acid- The scientific debate as a base for public health policy. Reproductive Toxicology 2005;20:411-5
de Jong-van den Berg LTW, Hernandez-Diaz S, Werler MM, Louik C, Mitchell AA.Trends and predictors of folic acid awareness and periconceptional use in pregnant women. American Journal of Obstetrics and Gynecology2005;192:121-8
de Jong JCF, Brouwers JRBJ, de Jong-van den Berg LTW.Combined use of NSAIDs and SSRIs increases the risk for gastrointestinal adverse effects. British Journal of Clinical Pharmacology 2005;59(1):119-(letter).
Duyvendak M, Naunton M, Peterson GM, Brouwers JRBJ. A pilot study of doctors' beliefs and knowledge on corticosteroid-induced osteoporosis prevention: identifying barriers to improve practice. The European Journal of Hospital Pharmacy Science 2005;11(5):114-20
Duyvendak M, Naunton M, Kingma BJ, Brouwers JRBJ.Thalidomide-associated thrombocytopenia. The Annals of Pharmacotherapy 2005;39(nov):1936-9
Ehrensberger U, Vasel-Biergans A, Dhillon S, Heide L, Taxis K. Evaluation of a British-German postgraduate course in clinical pharmacy. Pharmacy Education 2005;5(1):7-11
Faber A, de Jong-van den Berg LTW, van den Berg PB, Tobi H. Psychotropic Co-Medication among Stimulant-Treated Children in the Netherlands. Journal of Child and Adolescent Psychopharmacology 2005;15(1):38-43
Faber A, de Jong-van den Berg LTW, Netjes KA, Kalverdijk L, Minderaa RB, Tobi H. Recruitment of parents and physicians of stimulant-using children via community pharmacies is succesfull. Journal of Clinical Epidemiology2005;58:1072-3
Faber A, Bouvy ML, Loskamp L, van de Berg PB, Egberts ACG, de Jong-van den Berg LTW.Dramatic change in prescribing of hormone replacement therapy in the Netherlands after publications of the million women study: a follow-up study. British Journal of Clinical Pharmacology2005;60(6):641-7
Fokkema MR, Meijer WM, de Jong-van den Berg LTW.Benefits and concerns regarding folic-acid fortification. Ned Tijdschr Klin Chem Labgeneesk2005;30(3):218-23
Jansman FGA, jansen AJA, Coenen JLL, de Graaf J, Smit WM, Sleijfer DTh, Brouwers JRBJ.Assessing the clinical significance of drug interactions in patients with colorectal cancer. American Journal of Health-System Pharmacy 2005;62(17):1788-92
Jansman FGA, Idzinga FSF, Smit WM, de Graaf J, Coenen JLLM, Sleijfer DTh, Brouwers JRBJ.Classification and Occurence of clinically significant drug interactions with irinotecan and oxaliplatin in patients with metastatic clocrectal cancer. Clinical Therapeutics2005;27(3):327-35
Klok RM, Brouwer WBF, Annemans LJP, Bos JM, Postma MJ.Towards a healthier discount procedure. Expert Reviews Pharmacoeconomics Outcomes research 2005;5(1):59-63
Klok RM, Postma MJ, van Hout BA, Brouwers JRBJ.All proton pump inhibitors are equivalent for treatment of GERD. Cleveland Clinical Journal of Medicine 2005;72(12):1100
Klok RM, Arents NLA, de Vries R, Thijs JC, Brouwers JRBJ, Kleibeuker JH, Postma MJ.Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting. Clinical Therapeutics2005;27(10):1647-57
Meijer WM, de Walle HEK, Kerstjens-Frederikse WS, de Jong-van den Berg LTW.Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Reproductive Toxicology2005;20:203-7
Meijer WM, de Smit DJ, Jurgens RA, de Jong-van den Berg LTW.Improved periconceptional use of folic acid after patient education in pharmacies: promising results of a pilot study in the Netherlands. International Journal of Pharmacy Practice (IJPP) 2005;13:47-51
Naunton M, Peterson GM. Don't forget the evidence - Alzheimer's disease. Australian Pharmacist 2005;24(11):878-81
Naunton M. The 'D' ilemma - ensuring the elderly fall in love with vitamin D. Pharmacist 2005;24(7):563-6
Naunton M, Peterson GM. Newley diagnosed asthma in a child. Pharmacist 2005;24(6):448-51
Naunton M, Duyvendak M. Underuse of antiplatelets and inapproriate use. Eur J Clin Pharmacol 2005;61(11):Letter to the Editors-80
Naunton M, Duyvendak M, Peterson GM, Brouwers JRBJ. Comments on Glintborg et al.'s drug-drug interactions study (EJCP 2005; 61:675-681). Eur J Clin Pharmacol 2005;(jan.):Letter to the Editors-(letter).
Naunton M, Peterson GM, Jones G. The role of community pharmacy in screening for osteoporosis. Pharmacist 2005;24(6):484-7.
Naunton M, Peterson GM, Bereznicki L, Jackson S. The enigma of aspirin in primary prevention. Pharmacist 2005;24(9):718-22.
Peterson GM, Naunton M. Valproate: a simple chemical with so much to offer. Journal of Clinical Pharmacy and Therapeutics 2005;30:417-21
Postma MJ, Jansema P, Scheijbeler HWKFH, van Genugten MLL.Scenarios on costs and savings of influenza treatment and prevention for Dutch healthy working adults. Vaccine 2005;23(June):5365-71
Postma MJ, van Hulst M, de Wolf JTM, Botteman M, Staginnus U. Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands. Transfusion Medicine2005;15:379-87
Reinders MK, van Roon EN, Brouwers JRBJ, Jansen TLThA.A costly therapeutic dilemma in tophaceous gout: is etanercept or rasburicase preferable? Ann Rheum Dis2005;64:516-(letter).
Rijcken CAW, Knegterink H, Bruggeman R, Tobi H, de Jong-van den Berg LTW.Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication. Psychiatric Research2005;134(2):143-50
Schaafsma ES. Counselling, concordance, and communication: innovative education for pharmacists. In: Tana Wuliji MA, ed. Counselling, concordance, and communication: innovative education for pharmacists.Portugal: Visão Gráfica, 2005:17-20
Smink BE, Ruiter B, Lusthof KJ, de Gier JJ, Uges DRA, Egberts ACG.Drug use and the severity of a traffic accident. Accident Analysis & Prevention 2005;37:427-33
Stuurman-Bieze AGG., Kokenberg MEAP, Tobi H, de Boer WO, van Doormaal JE, de Jong-van den Berg LTW, Tromp ThFJ.Complex pharmaceutical care intervention in pulmonary care. Part B. Patient opinion and process survey. Pharmacy World & Science2005;27:385-92
Stuurman-Bieze AGG., de Boer O., Kokenberg MEAP, Hugtenburg JG, de Jong-van den Berg LTW, Tromp ThFJ.Complex pharmaceutical care intervention in pulmonary care. Part A. The process and pharmacists' professional satisfaction. Pharmacy World & Science 2005;27:376-84
Taxis K. Who is responsible for the safety of infusion devices? It's high time for action! Quality Safety Health Care 2005;14:76 (letter)
Tobi H, Scheers T, Netjes KA, Mulder EJ, de Bildt A, Minderaa RB.Drug utilisation by children and adolescents with mental retardation: a population study. Eur J Clin Pharmacol2005;61:297-302
Tobi H, van den Berg PB, de Jong-van den Berg LTW.Small proportions: what to report for confidence intervals? Pharmacoepidemiology and Drug Safety2005;14:239-47.
van Grootheest AC, de Jong-van den Berg LTW.The role of hospital and community pharmacists in pharmacovigilance. Research in Social and Administrative Pharmacy 2005;1(126):33
van Hulst M, Bilgin Y, van de Watering LMG, de Vries R, van Oers MHJ, Brand A, Postma MJ. Cost-effectiveness of leucocyte-depleted erythrocyte transfusion in cardiac valve surgery. Transfusion Medicine2005;15:209-17
van Roon EN, Flikweert S, le Comte M, Langendijk PJN, Kwee-Zuiderdijk WJM, Smits P, Brouwers JRBJ. Clinical relevance of drug-drug interactions. Drug Safety 2005;28(12):1131-9
van Roon EN, Hoekstra M, Tobi H, Jansen TLTA, Bernelot Moens HJ, Brouwers JRBJ, van de Laar MAFJ.Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation. British Journal of Clinical Pharmacology2005;60(3):319-25
van Roon EN, Jansen TLTA, van de Laar MAFJ, Yska JP, Keuper R, Houtman PM, Brouwers JRBJ.Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response tot treatment in patients with rheumatoid arthritis. Ann Rheum Dis2005;64:569-74
Veurink M, Koster M, de Jong-van den Berg LTW.The history of DES, lessons to be learned. Pharmacy World & Science 2005;27:139-43
Welte R, Postma MJ, Leidl R, Kretzschmar M. Costs and effects of clamydial screening: dynamic versus static modeling. Sexually Transmitted Diseases 2005;32(8):474-83
Welte R, Trotter CL, Edmunds WJ, Postma MJ, Beutels PH.The role of economic evaluation in vaccine decision making. Pharmacoeconomics 2005;23(9):855-74
Wilffert B, Zaal R, Brouwers JRBJ.Pharmacogenetics as a tool in the therapy of schizophrenia. Pharmacy World & Science 2005;27:20-30
Wilting I, Movig KLL, Moolenaar M, Hekster YA, Brouwers JRBJ, Heerdink ER, Nolen WA, Egberts ACG.Drug-drug interactions as a determinant of elevated lithium serum levels in daily clinical practice. Bipolar Disorders2005;7:274-80
Otten MH, Frankhuisen R, Brouwers JRBJ, Exalto N. Welke antacida genieten de voorkeur in de zwangerschap? Nederlands Tijdschrift voor Obstetrie & Gynaecologie 2005;118:176-7
Postma MJ. Farmaco-economische evaluatie bestrijding MRSA-uitbraak. Nederlands Tijdschrift voor Medische Microbiologie 2005;13(1):19-21
Vroom F, de Jong PH, van den Berg PB, Tobi H, de Jong-van den Berg LTW. Gebruik van orale conceptiva in de jaren 1994-2002: wel anders, niet minder. Nederlands Tijdschrift Geneeskunde 2005;149(1):23-8
Professional Publications
Boeke GM, Jansman FGA, Coenen JLLM, de Graaf J, Harting JW, Brouwers JRBJ. Irinotecan en SN-38 bij patiënten met gemetastaseerde colorectale kanker. Toxiciteit voorspellen met AUC en C_max. Pharmaceutisch Weekblad 2005;140(3):96-9
Brouwers JRBJ, Duyvendak M, van Roon EN. Commentaar op de NHG-Standaard Osteoperose (eerste herziening). Broze botten nog steeds niet transmuraal. Pharmaceutisch Weekblad 2005;47(25 nov.):1488-1510
de Gier JJ. Samenspraak als geneesmiddel. Concordance helpt artsen en patiënten bij goed gebruik van medicatie. Medisch Contact 2005;60(46):1848-51
de Jong-van den Berg LTW, de Smit DJ. Apothekers hebben zorg voor vrouwen met kinderwens. Klaar voor de uitdaging. Pharmaceutisch Weekblad 2005;140(39):1213-4
Faber A, Tobi H. Atomoxetine (Strattera). Pharmaceutisch Weekblad2005;140(23):774-7
Lems WF, Bijlsma JWJ, Brouwers JRBJ. Consensus over praktische afhandeling. Maagdarmklachten door biofosfonaten. Pharmaceutisch Weekblad 2005;47(25 nov):149-51
Loonen AJM. Mensen met chronische psychiatrische problemen zijn de grote verliezers. Huisarts in Nederland 2005;10:16-7
Loonen AJM. Depressie als 'tob'stoornis en als 'lust'stoornis. Patient Care 2005;special(november):11-5
Loonen AJM. Vaker van de geëigende paden afwijken. Pharmaceutisch Weekblad 2005;140(26/27):875-6
Loonen AJM. Op zoek naar nieuwe behandelingen van psychotische stoornissen. Patient Care / Neuropsychiatrie & Gedragsneurologie 2005;(aug.):151-3
Postma MJ. Oseltamivir economisch gunstig bij risicopatiënten. Pharmaceutisch Weekblad 2005;140(24):816-8
Taxis K, Kloft C. Interaktionsproblematik in der Pharmakotherapie mit Immunsuppressiva. Pharm Unserer Zeit2005;34(4):332-43
Zoet NAF, Harting JW, Brouwers JRBJ. Een geneesmiddel op zoek naar een ziekte. Interleukine 10 kent zijn plaats nog niet. Pharmaceutisch Weekblad 2005;140(23):781-4
Book Whole
Buurma H, Beudeker HJ, de Jong-van den Berg LTW, Leufkens HGM. Het geneesmiddel. 4 ed. Maarssen: Elsevier, 2005
Pieters A. Interferon. The science and selling of a miracle drug.Atlanta: Routledge, 2005
Book Chapter
de Jong-van den Berg LTW, de Smit DJ. Communicatie. In: Buurma H, Beudeker HJ, de Jong-van den Berg LTW, Leufkens HGM, eds. Het geneesmiddel.Maarssen: Elsevier, 2005:188-210
de Vries CS, de Jong-van den Berg LTW.Spontane rapportage en farmaco-epidemiologie.In: Buurma H, Beudeker HJ, de Jong-van den Berg LTW, Leufkens HGM, eds.Het geneesmiddel.Maarssen: Elsevier, 2005:212-29
Schaafsma ES. Counselling, Concordance, and Communication: innovative education for pharmacists.Portugal: Visão Gráfica, 2005:17-20
van Luijn JCF, Postma MJ. Regulering van de vraag naar geneesmiddelen. In: Buurma H, Beudeker HJ, de Jong-van den Berg LTW, Leufkens HGM, eds.Het geneesmiddel.Maarssen: Elsevier, 2005:86-105

Laatst gewijzigd:

12 februari 2024 12:45